Bronchogen is a Khavinson tetrapeptide, Ala-Glu-Asp-Leu (AEDL), aimed at bronchial and respiratory tissue. The bioregulator premise is that a very short peptide can normalize gene expression in one specific organ and support repair there. Evidence is preliminary and largely Russian, which makes it an open research question rather than a settled one.
- A four amino acid Khavinson bioregulator (Ala-Glu-Asp-Leu) with the bronchial and respiratory tract as its target tissue.PubMed: bronchogen
- Proposed to normalize tissue-specific gene expression and support repair in its target organ, the shared mechanism claim across this peptide class.PubMed: bronchogen
- The evidence base is largely Russian research, with limited Western RCTs to date.thepeptidereport
- No well-characterized drug interactions have been reported for it to date.researchdosing
- Reported as generally well tolerated, with mild local reactions the main note, though human safety data remain limited.researchdosing